EX-ELIXIS, INC
EX-ELIXIS, INC Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20080229435 | Mapks as Modifiers of the Rac, Axin, and Beta-Catenin Pathways and Methods of Use - Human MAPK genes are identified as modulators of the Rac, axin, and beta-catenin pathways, and thus are therapeutic targets for disorders associated with defective Rac, axin, and beta-catenin function. Methods for identifying modulators of Rac, axin, and beta-catenin, comprising screening for agents that modulate the activity of MAPK are provided. | 09-18-2008 |